Supplemental new drug application
FDA Acceptance of sNDA for Fifth BRUKINSA Indication Announced by BeiGene
SG Tylor
Source – Beigene BeiGene, a prominent global biotechnology company, made a groundbreaking announcement today. The US Food and Drug Administration ...
Zanubrutinib Plus Obinutuzumab for R/R Follicular Lymphoma Receives FDA Acceptance of sNDA
SG Tylor
Source – BeiGene BeiGene has announced that the FDA has accepted a supplemental new drug application (sNDA) for the combination ...
